About this trial
Femoral heads will be collected at University Hospital (London, ON, Canada) from individuals with type-2 diabetes, obesity, and no T2D/no obesity controls. The femoral head will be taken to the Robarts Research Institute (London, ON, Canada) for lineage-restricted progenitor cell expansion and analyses. There the femoral heads will be used to isolate three stem cell types - Multipotent Stromal Cells, Endothelial Colony Forming Cells, and Hematopoietic Progenitor Cells. The yield and cell surface markers expressed on these cells will be measured using flow cytometry. These cell types will then undergo further analyses of the secretome, tubule forming assays, vascular regenerative cell exhaustion assays, and will be transplanted into immune deficient mice with with femoral artery ligation. These experiments are to assess the differences in function and expression of these cell types between individuals with type-2 diabetes and/or obesity and/or healthy controls.
Eligibility criteria
Qualifiers
Must be 18+ years of age
Disqualifiers
Diagnosis of bone cancers
Diagnosis of Rheumatoid arthritis
Diagnosis of hematopoietic conditions
Diagnosis of avascular necrosis of the hip
Trial design
Treatments tested in this trial
- Hip Replacement
Treatment groups
Locations
Sponsors and collaborators
David Hess
Lead sponsor
Western University, Canada
Sponsor institution